These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 3464282

  • 1. Gemfibrozil treatment and the relationship between HDL cholesterol and apoE distribution in cholesterol-fed rats.
    Krause BR, Newton RS.
    Atherosclerosis; 1986 Sep; 61(3):245-8. PubMed ID: 3464282
    [No Abstract] [Full Text] [Related]

  • 2. Clinical results with gemfibrozil.
    Pickering JE.
    Am J Cardiol; 1983 Aug 22; 52(4):39B-40B. PubMed ID: 6351579
    [No Abstract] [Full Text] [Related]

  • 3. Gemfibrozil in the treatment of dyslipidaemia. A 5-year follow-up study.
    Manninen V, Mälkönen M, Eisalo A, Virtamo J, Tuomilehto J, Kuusisto P.
    Acta Med Scand Suppl; 1982 Aug 22; 668():82-7. PubMed ID: 6762809
    [No Abstract] [Full Text] [Related]

  • 4. Influence of gemfibrozil and clofibrate on metabolism of cholesterol and plasma triglycerides in man.
    Kesäniemi YA, Grundy SM.
    JAMA; 1984 May 04; 251(17):2241-6. PubMed ID: 6368883
    [Abstract] [Full Text] [Related]

  • 5. The treatment of hyperlipoproteinaemia with gemfibrozil compared with placebo and clofibrate.
    Nye ER, Sutherland WH, Temple Wa.
    N Z Med J; 1980 Nov 12; 92(671):345-9. PubMed ID: 6935550
    [Abstract] [Full Text] [Related]

  • 6. Apolipoprotein changes associated with the plasma lipid-regulating activity of gemfibrozil in cholesterol-fed rats.
    Krause BR, Newton RS.
    J Lipid Res; 1985 Aug 12; 26(8):940-9. PubMed ID: 3862732
    [Abstract] [Full Text] [Related]

  • 7. Gemfibrozil increases both apo A-I and apo E concentrations. Comparison to other lipid regulators in cholesterol-fed rats.
    Krause BR, Newton RS.
    Atherosclerosis; 1986 Jan 12; 59(1):95-8. PubMed ID: 3081014
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Long-term use of gemfibrozil (Lopid) in the treatment of dyslipidemia.
    Lewis JE.
    Angiology; 1982 Sep 12; 33(9):603-12. PubMed ID: 6957156
    [Abstract] [Full Text] [Related]

  • 10. Gemfibrozil therapy in primary hypertriglyceridemia associated with coronary heart disease. Effects on metabolism of low-density lipoproteins.
    Vega GL, Grundy SM.
    JAMA; 1985 Apr 26; 253(16):2398-403. PubMed ID: 3856692
    [Abstract] [Full Text] [Related]

  • 11. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.
    Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P, Huttunen JK, Kaitaniemi P, Koskinen P, Manninen V.
    N Engl J Med; 1987 Nov 12; 317(20):1237-45. PubMed ID: 3313041
    [Abstract] [Full Text] [Related]

  • 12. Effects of gemfibrozil on plasma lipoprotein-apolipoprotein distribution and platelet reactivity in patients with hypertriglyceridemia.
    Sirtori CR, Franceschini G, Gianfranceschi G, Sirtori M, Montanari G, Tremoli E, Maderna P, Colli S, Zoppi F.
    J Lab Clin Med; 1987 Sep 12; 110(3):279-86. PubMed ID: 3475394
    [Abstract] [Full Text] [Related]

  • 13. Lessons from the Helsinki Heart Study. Fibric acid therapy for dyslipidemia.
    Grundy SM.
    Postgrad Med; 1988 Jul 12; 84(1):217-8, 223-31. PubMed ID: 3164473
    [No Abstract] [Full Text] [Related]

  • 14. Change in composition of high density lipoprotein during gemfibrozil therapy.
    Sorisky A, Ooi TC, Simo IE, Meuffels M, Hindmarsh JT, Nair R.
    Atherosclerosis; 1987 Oct 12; 67(2-3):181-9. PubMed ID: 3118893
    [Abstract] [Full Text] [Related]

  • 15. Effect of cholesterol feeding on apo B and apo E concentrations and distributions in euthyroid and hypothyroid rats.
    DeLamatre JG, Roheim PS.
    J Lipid Res; 1981 Feb 12; 22(2):297-306. PubMed ID: 7240959
    [Abstract] [Full Text] [Related]

  • 16. Treatment of type III hyperlipoproteinemia with four different treatment regimens.
    Hoogwerf BJ, Bantle JP, Kuba K, Frantz ID, Hunninghake DB.
    Atherosclerosis; 1984 Feb 12; 51(2-3):251-9. PubMed ID: 6588975
    [Abstract] [Full Text] [Related]

  • 17. Clinical results with gemfibrozil and background to the Helsinki Heart Study.
    Manninen V.
    Am J Cardiol; 1983 Aug 22; 52(4):35B-38B. PubMed ID: 6351578
    [No Abstract] [Full Text] [Related]

  • 18. Gemfibrozil, lipids, and coronary risk.
    Rifkind BM.
    N Engl J Med; 1987 Nov 12; 317(20):1279-81. PubMed ID: 3313042
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.